Genistein treatment increases bone mass in obese, hyperglycemic mice

References

• Ogden CL Carroll MD Kit BK Flegal KM Prevalence of childhood and adult obesity in the United States, 2011–2012 JAMA 2014 311 806 814 24570244
   PubMed Web of Science ®Google Scholar
• de Liefde II van der Klift M de Laet CE van Daele PL Hofman A Pols HA Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study Osteoporos Int 2005 16 1713 1720 15940395
   PubMed Web of Science ®Google Scholar
• Dede AD Tournis S Dontas I Trovas G Type 2 diabetes mellitus and fracture risk Metabolism 2014 63 1480 1490 25284729
   PubMed Web of Science ®Google Scholar
• Bonds DE Larson JC Schwartz AV Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study J Clin Endocrinol Metab 2006 91 3404 3410 16804043
   PubMed Web of Science ®Google Scholar
• Garg R Chen Z Beck T Hip geometry in diabetic women: implications for fracture risk Metabolism 2012 61 1756 1762 22726843
   PubMed Web of Science ®Google Scholar
• Burghardt AJ Issever AS Schwartz AV High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 2010 95 5045 5055 20719835
   PubMed Web of Science ®Google Scholar
• Leslie WD Rubin MR Schwartz AV Kanis JA Type 2 diabetes and bone J Bone Miner Res 2012 27 2231 2237 23023946
   PubMed Web of Science ®Google Scholar
• Hamrick MW Ferrari SL Leptin and the sympathetic connection of fat to bone Osteoporos Int 2008 19 905 912 17924050
   PubMed Web of Science ®Google Scholar
• Wauters M Considine RV Yudkin JS Peiffer F De Leeuw I Van Gaal LF Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion Horm Metab Res 2003 35 92 96 12734788
   PubMed Web of Science ®Google Scholar
• Donahue RP Prineas RJ Donahue RD Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study Diabetes Care 1999 22 1092 1096 10388973
   PubMed Web of Science ®Google Scholar
• Zimmet P Boyko EJ Collier GR de Courten M Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players Ann N Y Acad Sci 1999 892 25 44 10842650
   PubMed Web of Science ®Google Scholar
• Lewis GF Carpentier A Adeli K Giacca A Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr Rev 2002 23 201 229 11943743
   PubMed Web of Science ®Google Scholar
• Sethi JK Vidal-Puig AJ Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation J Lipid Res 2007 48 1253 1262 17374880
   PubMed Web of Science ®Google Scholar
• Correia ML Rahmouni K Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome Diabetes Obes Metab 2006 8 603 610 17026484
   PubMed Web of Science ®Google Scholar
• Gu X Chen Z El Bayoumy I Serum leptin levels in obese women with and without type 2 diabetes mellitus Minerva Endocrinol 2014 39 223 229 24819932
   PubMed Web of Science ®Google Scholar
• Reinehr T Woelfle J Wiegand S Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents Pediatr Diabetes Epub 2015 4 16
   Google Scholar
• Hamrick MW Pennington C Newton D Xie D Isales C Leptin deficiency produces contrasting phenotypes in bones of the limb and spine Bone 2004 34 376 383 15003785
   PubMed Web of Science ®Google Scholar
• Muzzin P Eisensmith RC Copeland KC Woo SL Correction of obesity and diabetes in genetically obese mice by leptin gene therapy Proc Natl Acad Sci USA 1996 93 14804 14808 8962136
   PubMed Web of Science ®Google Scholar
• Kishida Y Hirao M Tamai N Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification Bone 2005 37 607 621 16039170
   PubMed Web of Science ®Google Scholar
• Bartell SM Rayalam S Ambati S Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice J Bone Miner Res 2011 26 1710 1720 21520275
   PubMed Web of Science ®Google Scholar
• Fitzpatrick LA Estrogen therapy for postmenopausal osteoporosis Arq Bras Endocrinol Metabol 2006 50 705 719 17117296
   PubMedGoogle Scholar
• Nevitt MC Cummings SR Lane NE Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women Arch Intern Med 1996 156 2073 2080 8862099
   PubMed Web of Science ®Google Scholar
• Zhang Y McAlindon TE Hannan MT Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study Arthritis Rheum 1998 41 1867 1873 9778229
   PubMed Web of Science ®Google Scholar
• Spector TD Nandra D Hart DJ Doyle DV Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study Ann Rheum Dis 1997 56 432 434 9486006
   PubMed Web of Science ®Google Scholar
• Pelleymounter MA Baker MB McCaleb M Does estradiol mediate leptin’s effects on adiposity and body weight? Am J Physiol 1999 276 955 963
   Google Scholar
• Beral V Bull D Doll R Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer Lancet 1997 350 1047 1059 10213546
   PubMed Web of Science ®Google Scholar
• Beral V Banks E Reeves G Breast cancer and hormone-replacement therapy: the Million Women Study Lancet 2003 362 1330 1331
   Web of Science ®Google Scholar
• Kim HK Nelson-Dooley C Della-Fera MA Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice J Nutr 2006 136 409 414 16424120
   PubMed Web of Science ®Google Scholar
• Clarkson TB Anthony MS Williams JK Honoré EK Cline JM The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy Proc Soc Exp Biol Med 1998 217 365 368 9492349
   PubMed Web of Science ®Google Scholar
• Brzezinski A Debi A Phytoestrogens: the “natural” selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999 85 47 51 10428321
   PubMed Web of Science ®Google Scholar
• Atteritano M Mazzaferro S Bitto A Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study Osteoporos Int 2014 25 1123 1129 24114397
   PubMed Web of Science ®Google Scholar
• Bouker KB Hilakivi-Clarke L Genistein: does it prevent or promote breast cancer? Environ Health Perspect 2000 108 701 708 10964789
   PubMed Web of Science ®Google Scholar
• Seo HS DeNardo DG Jacquot Y Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha Breast Cancer Res Treat 2006 99 121 134 16541309
   PubMed Web of Science ®Google Scholar
• Levis S Strickman-Stein N Ganjei-Azar P Xu P Doerge DR Krischer J Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial Arch Intern Med 2011 171 1363 1369 21824950
   PubMed Web of Science ®Google Scholar
• Tai TY Tsai KS Tu ST The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study Osteoporos Int 2012 23 1571 1580 21901480
   PubMed Web of Science ®Google Scholar
• Hu XJ Xie MY Kluxen FM Diel P Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells Arch Toxicol 2014 88 625 635 24504162
   PubMed Web of Science ®Google Scholar
• Atteritano M Pernice F Mazzaferro S Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebocontrolled study Eur J Pharmacol 2008 589 22 26 18541232
   PubMed Web of Science ®Google Scholar
• Marini H Bitto A Altavilla D Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study J Clin Endocrinol Metab 2008 93 4787 4796 18796517
   PubMed Web of Science ®Google Scholar
• Bitto A Polito F Atteritano M Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebocontrolled trial J Clin Endocrinol Metab 2010 95 3067 3072 20357174
   PubMed Web of Science ®Google Scholar
• Russo M Russo GL Daglia M Understanding genistein in cancer: the “good” and the “bad” effects: a review Food Chem 2016 196 589 600 26593532
   PubMed Web of Science ®Google Scholar
• McClain RM Wolz E Davidovich A Edwards J Bausch J Reproductive safety studies with genistein in rats Food Chem Toxicol 2007 45 1319 1332 17433519
   PubMed Web of Science ®Google Scholar
• Messina M Ho S Alekel DL Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data Curr Opin Clin Nutr Metab Care 2004 7 649 658 15534433
   PubMed Web of Science ®Google Scholar
• McCarty MF Isoflavones made simple – genistein’s agonist activity for the beta-type estrogen receptor mediates their health benefits Med Hypotheses 2006 66 1093 1114 16513288
   PubMed Web of Science ®Google Scholar
• Chanawirat A Khemapech S Patumraj S Siriviriyakul P Genistein replacement therapy on endothelial dysfunction and bone loss in bilateral ovariectomized rats Clin Hemorheol Microcirc 2006 34 309 314 16543651
   PubMed Web of Science ®Google Scholar
• Erlandsson MC Islander U Moverare S Ohlsson C Carlsten H Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice APMIS 2005 113 317 323 16011657
   PubMed Web of Science ®Google Scholar
• Bitto A Burnett BP Polito F Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol Br J Pharmacol 2008 155 896 905 18695641
   PubMed Web of Science ®Google Scholar
• Chen YM Ho SC Lam SS Ho SS Woo JL Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial Menopause 2004 11 246 254 15167303
   PubMed Web of Science ®Google Scholar
• Wu J Oka J Higuchi M Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial Metabolism 2006 55 423 433 16546471
   PubMed Web of Science ®Google Scholar
• Morabito N Crisafulli A Vergara C Effects of genistein and hormone replacement therapy on bone loss in early postmenopausal women: a randomized double blind placebo – controlled study J Bone Miner Res 2002 17 1904 1912 12369794
   PubMed Web of Science ®Google Scholar
• Marini H Minutoli L Polito F Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial Ann Intern Med 2007 146 839 847 17577003
   PubMed Web of Science ®Google Scholar
• Claassen H Briese V Manapov F Nebe B Schünke M Kurz B The phytoestrogens daidzein and genistein enhance the insulin-stimulated sulfate uptake in articular chondrocytes Cell Tissue Res 2008 333 71 79 18509682
   PubMed Web of Science ®Google Scholar
• Kim RP Edelman SV Kim DD Musculoskeletal complications of diabetes mellitus Clin Diabetes 2001 19 132 135
   Google Scholar
• Bergink AP van Meurs JB Loughlin J Estrogen receptor α gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women Arthritis Rheum 2003 48 1913 1922 12847685
   PubMed Web of Science ®Google Scholar
• Spector TD Campion GD Generalised osteoarthritis: a hormonally mediated disease Ann Rheum Dis 1989 48 523 2662920
   PubMed Web of Science ®Google Scholar
• Ushiyama T Ueyama H Inoue K Nishioka J Ohkubo I Hukuda S Estrogen receptor gene polymorphism and generalized osteoarthritis J Rheumatol 1998 25 134 137 9458216
   PubMed Web of Science ®Google Scholar
• Al-Nakkash L Clarke LL Rottinghaus GE Chen YJ Cooper K Rubin LJ Dietary genistein stimulates anion secretion across female murine intestine J Nutr 2006 136 2785 2790 17056801
   PubMed Web of Science ®Google Scholar
• Barnes S Sfakianos J Coward L Kirk M Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues Adv Exp Med Biol 1996 401 87 100 8886128
   PubMedGoogle Scholar
• Sfakianos J Coward L Kirk M Barnes S Intestinal uptake and biliary excretion of the isoflavone genistein in rats J Nutr 1997 127 1260 1268 9202077
   PubMed Web of Science ®Google Scholar
• Xu X Wang HJ Murphy PA Cook L Hendrich S Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women J Nutr 1994 124 825 832 8207540
   PubMed Web of Science ®Google Scholar
• Hsieh CY Santell RC Haslam SZ Helferich WG Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res 1998 58 3833 3838 9731492
   PubMed Web of Science ®Google Scholar
• Ducy P Amling M Takeda S Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 2000 100 197 207 10660043
   PubMed Web of Science ®Google Scholar
• Burguera B Hofbauer LC Thomas T Leptin reduces ovariectomy-induced bone loss in rats Endocrinology 2001 142 3546 3553 11459801
   PubMed Web of Science ®Google Scholar
• Takeda S Elefteriou F Levasseur R Leptin regulates bone formation via the sympathetic nervous system Cell 2002 111 305 317 12419242
   PubMed Web of Science ®Google Scholar
• Liu LF Shen WJ Ueno M Patel S Azhar S Kraemer FB Age-related modulation of the effects of obesity on gene expression profiles of mouse bone marrow and epididymal adipocytes PLoS One 2013 8 e72367 23967297
   PubMed Web of Science ®Google Scholar
• Zhang J Li T Xu L Leptin promotes ossification through multiple ways of bone metabolism in osteoblast: a pilot study Gynecol Endocrinol 2013 29 758 762 23706140
   PubMed Web of Science ®Google Scholar
• Turner RT Kalra SP Wong CP Peripheral leptin regulates bone formation J Bone Miner Res 2013 28 22 34 22887758
   PubMed Web of Science ®Google Scholar
• Mittendorfer B Horowitz JF DePaoli AM McCamish MA Patterson BW Klein S Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes Diabetes 2011 60 1474 1477 21411512
   PubMed Web of Science ®Google Scholar
• Andersson B Mattsson LA Hahn L Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 1997 82 638 643 9024268
   PubMed Web of Science ®Google Scholar
• Bhathena SJ Velasquez MT Beneficial role of dietary phytoestrogens in obesity and diabetes Am J Clin Nutr 2002 76 1191 1201 12450882
   PubMed Web of Science ®Google Scholar
• Fu Z Zhang W Zhen W Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice Endocrinology 2010 151 3026 3037 20484465
   PubMed Web of Science ®Google Scholar
• Naaz A Yellayi S Zakroczymski MA The soy isoflavone genistein decreases adipose deposition in mice Endocrinology 2003 144 3315 3320 12865308
   PubMed Web of Science ®Google Scholar
• Yu SB Wang MQ Li YQ The effects of age and sex on the expression of oestrogen and its receptors in rat mandibular condylar cartilages Arch Oral Biol 2009 54 479 485 19264293
   PubMed Web of Science ®Google Scholar
• Yu SB Xing XH Dong GY Weng XL Wang MQ Excess genistein suppresses the synthesis of extracellular matrix in female rat mandibular condylar cartilage Acta Pharmacol Sin 2012 33 918 923 22705728
   PubMed Web of Science ®Google Scholar